[HTML] springer.com

[HTML][HTML] Tocilizumab in hospitalized patients with COVID-19: a meta analysis of randomized controlled trials

V Selvaraj, MS Khan, C Bavishi, K Dapaah-Afriyie… - Lung, 2021 - Springer
Background To date, only dexamethasone has been shown to reduce mortality in
coronavirus disease-19 (COVID-19) patients. Tocilizumab has been recently added to the …
被引用次数：35 相关文章

Tocilizumab in hospitalized patients with COVID-19: a meta analysis of randomized controlled trials.

V Selvaraj, MS Khan, C Bavishi, K Dapaah-Afriyie… - 2021 - cabidigitallibrary.org
Background: To date, only dexamethasone has been shown to reduce mortality in
coronavirus disease-19 (COVID-19) patients. Tocilizumab has been recently added to the …
[PDF] researchgate.net

[PDF][PDF] TOCILIZUMAB IN HOSPITALIZED PATIENTS WITH COVID-19: A META ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

V Selvaraj, MS Khan, K Dapaah-Afriyie, A Finn… - researchgate.net
Tocilizumab in hospitalized patients with COVID-19: A meta analysis of randomized controlled
trials Page 1 1 TOCILIZUMAB IN HOSPITALIZED PATIENTS WITH COVID-19: A META …
[HTML] nih.gov

[HTML][HTML] Tocilizumab in Hospitalized Patients with COVID-19: A Meta Analysis of Randomized Controlled Trials

V Selvaraj, MS Khan, C Bavishi, K Dapaah-Afriyie… - Lung, 2021 - ncbi.nlm.nih.gov
Tocilizumab in Hospitalized Patients with COVID-19: A Meta Analysis of Randomized Controlled
Trials - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage …
[PDF] academia.edu

[PDF][PDF] Tocilizumab in Hospitalized Patients with COVID‑19: A Meta Analysis of Randomized Controlled Trials

V Selvaraj, MS Khan, C Bavishi, K Dapaah‑Afriyie… - Lung, 2021 - academia.edu
Background To date, only dexamethasone has been shown to reduce mortality in
coronavirus disease-19 (COVID-19) patients. Tocilizumab has been recently added to the …

Tocilizumab in Hospitalized Patients with COVID-19: A Meta Analysis of Randomized Controlled Trials

V Selvaraj, MS Khan, C Bavishi, K Dapaah-Afriyie… - Lung, 2021 - pubmed.ncbi.nlm.nih.gov
Background To date, only dexamethasone has been shown to reduce mortality in
coronavirus disease-19 (COVID-19) patients. Tocilizumab has been recently added to the …
[PDF] archive.org

[PDF][PDF] TOCILIZUMAB IN HOSPITALIZED PATIENTS WITH COVID-19: A META ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

V Selvaraj, MS Khan, K Dapaah-Afriyie, A Finn… - scholar.archive.org
Tocilizumab in hospitalized patients with COVID-19: A meta analysis of randomized controlled
trials Page 1 1 TOCILIZUMAB IN HOSPITALIZED PATIENTS WITH COVID-19: A META …

Tocilizumab in Hospitalized Patients with COVID-19: A Meta Analysis of Randomized Controlled Trials.

V Selvaraj, MS Khan, C Bavishi, K Dapaah-Afriyie… - Lung, 2021 - search.ebscohost.com
Background: To date, only dexamethasone has been shown to reduce mortality in
coronavirus disease-19 (COVID-19) patients. Tocilizumab has been recently added to the …

Tocilizumab in Hospitalized Patients with COVID-19: A Meta Analysis of Randomized Controlled Trials.

V Selvaraj, MS Khan, C Bavishi, K Dapaah-Afriyie… - Lung, 2021 - europepmc.org
Tocilizumab in Hospitalized Patients with COVID-19: A Meta Analysis of Randomized Controlled
Trials. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu …

Tocilizumab in Hospitalized Patients with COVID-19: A Meta Analysis of Randomized Controlled Trials.

V Selvaraj, MS Khan, C Bavishi, K Dapaah-Afriyie… - Lung, 2021 - go.gale.com
Tocilizumab in Hospitalized Patients with COVID-19: A Meta Analysis of Randomized Controlled
Trials. - Document - Gale OneFile: Health and Medicine Use this link to get back to this page …